Targeting interleukin-1 in the treatment of rheumatoid arthritis
- PMID: 11920390
- DOI: 10.1002/art.10168
Targeting interleukin-1 in the treatment of rheumatoid arthritis
Erratum in
- Arthritis Rheum 2002 Jun;46(6):1690
Comment on
-
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.Arthritis Rheum. 2002 Mar;46(3):614-24. doi: 10.1002/art.10141. Arthritis Rheum. 2002. PMID: 11920396 Clinical Trial.
Similar articles
-
The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.Rheumatology (Oxford). 2003 May;42 Suppl 2:ii3-10. doi: 10.1093/rheumatology/keg326. Rheumatology (Oxford). 2003. PMID: 12817089 Review.
-
[Osteoporosis and rheumatoid arthritis].Clin Ter. 1991 Dec 15-31;139(5-6):241-5. Clin Ter. 1991. PMID: 1802512 Italian. No abstract available.
-
[Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].Bull Acad Natl Med. 2003;187(5):935-54; discussion 954-5. Bull Acad Natl Med. 2003. PMID: 14979058 Review. French.
-
Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.Arthritis Rheum. 2003 Dec;48(12):3308-19. doi: 10.1002/art.11358. Arthritis Rheum. 2003. PMID: 14673982 Review. No abstract available.
-
How antirheumatic drugs protect joints from damage in rheumatoid arthritis.Arthritis Rheum. 2008 Oct;58(10):2936-48. doi: 10.1002/art.23951. Arthritis Rheum. 2008. PMID: 18821703 Review. No abstract available.
Cited by
-
Mechanism of Emodin in the Treatment of Rheumatoid Arthritis.Evid Based Complement Alternat Med. 2022 Oct 3;2022:9482570. doi: 10.1155/2022/9482570. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36225183 Free PMC article. Review.
-
Immunomodulatory matrix-bound nanovesicles mitigate acute and chronic pristane-induced rheumatoid arthritis.NPJ Regen Med. 2022 Feb 2;7(1):13. doi: 10.1038/s41536-022-00208-9. NPJ Regen Med. 2022. PMID: 35110573 Free PMC article.
-
Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation.Sci Rep. 2021 Jun 15;11(1):12516. doi: 10.1038/s41598-021-92055-9. Sci Rep. 2021. PMID: 34131243 Free PMC article.
-
Bedside to bench: defining the immunopathogenesis of psoriatic arthritis.Nat Rev Rheumatol. 2019 Nov;15(11):645-656. doi: 10.1038/s41584-019-0285-8. Epub 2019 Sep 4. Nat Rev Rheumatol. 2019. PMID: 31485004 Review.
-
The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review.Front Immunol. 2019 May 24;10:1140. doi: 10.3389/fimmu.2019.01140. eCollection 2019. Front Immunol. 2019. PMID: 31178867 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
